APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

FIC Single-target Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global FIC Single-target Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173991820329 December 2025199 pages

Choose your research edition.

Industry ResearchFIC Single-target Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal FIC Single-target Drugs Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal FIC Single-target Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FIC Single-target Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal FIC Single-target Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global FIC Single-target Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for FIC Single-target Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for FIC Single-target Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FIC Single-target Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for FIC Single-target Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FIC Single-target Drugs include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer, Polarean lmaging and Phathom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global FIC Single-target Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of FIC Single-target Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents FIC Single-target Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the FIC Single-target Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

FIC Single-target Drugs Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Polarean lmaging

Phathom

Marinus

Mallinckrodt

ImmunoGen

Immunocore

Gilead

Genentech

Dermavant Sciences

Boehringer Ingelheim

BMS

Agios

FIC Single-target Drugs Segment by Type

ALK2 Inhibitors

Citron Inhibitors

GCN2 Agonists

RORγ Covalent Inhibitors

Others

FIC Single-target Drugs Segment by Application

Hospital

Clinic

Other

FIC Single-target Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FIC Single-target Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FIC Single-target Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FIC Single-target Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the FIC Single-target Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FIC Single-target Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of FIC Single-target Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of FIC Single-target Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. FIC Single-target Drugs Industry Trends Table 2. FIC Single-target Drugs Industry Drivers Table 3. FIC Single-target Drugs Industry Opportunities and Challenges Table 4. FIC Single-target Drugs Industry Restraints Table 5. Global FIC Single-target Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global FIC Single-target Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global FIC Single-target Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global FIC Single-target Drugs Sales Market Share by Manufacturers Table 9. Global FIC Single-target Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global FIC Single-target Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global FIC Single-target Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global FIC Single-target Drugs Manufacturers, Product Type & Application Table 13. Global FIC Single-target Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global FIC Single-target Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ALK2 Inhibitors Table 17. Major Manufacturers of Citron Inhibitors Table 18. Major Manufacturers of GCN2 Agonists Table 19. Major Manufacturers of RORγ Covalent Inhibitors Table 20. Major Manufacturers of Others Table 21. Global FIC Single-target Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global FIC Single-target Drugs Sales Market Share by Type (2021-2026) Table 25. Global FIC Single-target Drugs Sales Market Share by Type (2027-2032) Table 26. Global FIC Single-target Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global FIC Single-target Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global FIC Single-target Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026) Table 30. Global FIC Single-target Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Other Table 34. Global FIC Single-target Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global FIC Single-target Drugs Sales Market Share by Application (2021-2026) Table 38. Global FIC Single-target Drugs Sales Market Share by Application (2027-2032) Table 39. Global FIC Single-target Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global FIC Single-target Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global FIC Single-target Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2026) Table 43. Global FIC Single-target Drugs Revenue Market Share by Application (2027-2032) Table 44. Global FIC Single-target Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global FIC Single-target Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global FIC Single-target Drugs Sales Market Share by Region (2021-2026) Table 47. Global FIC Single-target Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global FIC Single-target Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global FIC Single-target Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global FIC Single-target Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global FIC Single-target Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global FIC Single-target Drugs Revenue Market Share by Region (2021-2026) Table 65. Global FIC Single-target Drugs Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi FIC Single-target Drugs Product Portfolio Table 70. Sanofi Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson FIC Single-target Drugs Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis FIC Single-target Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck FIC Single-target Drugs Product Portfolio Table 85. Merck Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Roche FIC Single-target Drugs Product Portfolio Table 90. Roche Recent Development Table 91. Eli Lilly Company Information Table 92. Eli Lilly Business Overview Table 93. Eli Lilly FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Eli Lilly FIC Single-target Drugs Product Portfolio Table 95. Eli Lilly Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pfizer FIC Single-target Drugs Product Portfolio Table 100. Pfizer Recent Development Table 101. Polarean lmaging Company Information Table 102. Polarean lmaging Business Overview Table 103. Polarean lmaging FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Polarean lmaging FIC Single-target Drugs Product Portfolio Table 105. Polarean lmaging Recent Development Table 106. Phathom Company Information Table 107. Phathom Business Overview Table 108. Phathom FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Phathom FIC Single-target Drugs Product Portfolio Table 110. Phathom Recent Development Table 111. Marinus Company Information Table 112. Marinus Business Overview Table 113. Marinus FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Marinus FIC Single-target Drugs Product Portfolio Table 115. Marinus Recent Development Table 116. Mallinckrodt Company Information Table 117. Mallinckrodt Business Overview Table 118. Mallinckrodt FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Mallinckrodt FIC Single-target Drugs Product Portfolio Table 120. Mallinckrodt Recent Development Table 121. ImmunoGen Company Information Table 122. ImmunoGen Business Overview Table 123. ImmunoGen FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. ImmunoGen FIC Single-target Drugs Product Portfolio Table 125. ImmunoGen Recent Development Table 126. Immunocore Company Information Table 127. Immunocore Business Overview Table 128. Immunocore FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Immunocore FIC Single-target Drugs Product Portfolio Table 130. Immunocore Recent Development Table 131. Gilead Company Information Table 132. Gilead Business Overview Table 133. Gilead FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Gilead FIC Single-target Drugs Product Portfolio Table 135. Gilead Recent Development Table 136. Genentech Company Information Table 137. Genentech Business Overview Table 138. Genentech FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Genentech FIC Single-target Drugs Product Portfolio Table 140. Genentech Recent Development Table 141. Dermavant Sciences Company Information Table 142. Dermavant Sciences Business Overview Table 143. Dermavant Sciences FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Dermavant Sciences FIC Single-target Drugs Product Portfolio Table 145. Dermavant Sciences Recent Development Table 146. Boehringer Ingelheim Company Information Table 147. Boehringer Ingelheim Business Overview Table 148. Boehringer Ingelheim FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Boehringer Ingelheim FIC Single-target Drugs Product Portfolio Table 150. Boehringer Ingelheim Recent Development Table 151. BMS Company Information Table 152. BMS Business Overview Table 153. BMS FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. BMS FIC Single-target Drugs Product Portfolio Table 155. BMS Recent Development Table 156. Agios Company Information Table 157. Agios Business Overview Table 158. Agios FIC Single-target Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Agios FIC Single-target Drugs Product Portfolio Table 160. Agios Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. FIC Single-target Drugs Distributors List Table 164. FIC Single-target Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. FIC Single-target Drugs Product Image Figure 2. Global FIC Single-target Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FIC Single-target Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global FIC Single-target Drugs Sales (2021-2032) & (K Units) Figure 5. Global FIC Single-target Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 FIC Single-target Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ALK2 Inhibitors Image Figure 9. Citron Inhibitors Image Figure 10. GCN2 Agonists Image Figure 11. RORγ Covalent Inhibitors Image Figure 12. Others Image Figure 13. Global FIC Single-target Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global FIC Single-target Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global FIC Single-target Drugs Sales Market Share by Type (2021-2032) Figure 16. Global FIC Single-target Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global FIC Single-target Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global FIC Single-target Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global FIC Single-target Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global FIC Single-target Drugs Sales Market Share by Application (2021-2032) Figure 25. Global FIC Single-target Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global FIC Single-target Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America FIC Single-target Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe FIC Single-target Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific FIC Single-target Drugs Sales Market Share by Country (2021-2032) Figure 42. China FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa FIC Single-target Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile FIC Single-target Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global FIC Single-target Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global FIC Single-target Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. FIC Single-target Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. FIC Single-target Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • ALK2 Inhibitors
  • Citron Inhibitors
  • GCN2 Agonists
  • RORγ Covalent Inhibitors
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Polarean lmaging
  • Phathom
  • Marinus
  • Mallinckrodt
  • ImmunoGen
  • Immunocore
  • Gilead
  • Genentech
  • Dermavant Sciences
  • Boehringer Ingelheim
  • BMS
  • Agios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global FIC Single-target Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global FIC Single-target Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global FIC Single-target Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global FIC Single-target Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global FIC Single-target Drugs Market Dynamics
  1. 2.1 FIC Single-target Drugs Industry Trends
  2. 2.2 FIC Single-target Drugs Industry Drivers
  3. 2.3 FIC Single-target Drugs Industry Opportunities and Challenges
  4. 2.4 FIC Single-target Drugs Industry Restraints
3 FIC Single-target Drugs Market by Manufacturers
  1. 3.1 Global FIC Single-target Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global FIC Single-target Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global FIC Single-target Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global FIC Single-target Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FIC Single-target Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global FIC Single-target Drugs Manufacturers, Product Type & Application
  7. 3.7 Global FIC Single-target Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FIC Single-target Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FIC Single-target Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FIC Single-target Drugs Tier 1, Tier 2, and Tier 3
4 FIC Single-target Drugs Market by Type
  1. 4.1 FIC Single-target Drugs Type Introduction
  2. 4.1.1 ALK2 Inhibitors
  3. 4.1.2 Citron Inhibitors
  4. 4.1.3 GCN2 Agonists
  5. 4.1.4 RORγ Covalent Inhibitors
  6. 4.1.5 Others
  7. 4.2 Global FIC Single-target Drugs Sales by Type
  8. 4.2.1 Global FIC Single-target Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global FIC Single-target Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global FIC Single-target Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global FIC Single-target Drugs Revenue by Type
  12. 4.3.1 Global FIC Single-target Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global FIC Single-target Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global FIC Single-target Drugs Revenue Market Share by Type (2021-2032)
5 FIC Single-target Drugs Market by Application
  1. 5.1 FIC Single-target Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global FIC Single-target Drugs Sales by Application
  6. 5.2.1 Global FIC Single-target Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global FIC Single-target Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global FIC Single-target Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global FIC Single-target Drugs Revenue by Application
  10. 5.3.1 Global FIC Single-target Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global FIC Single-target Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global FIC Single-target Drugs Revenue Market Share by Application (2021-2032)
6 Global FIC Single-target Drugs Sales by Region
  1. 6.1 Global FIC Single-target Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global FIC Single-target Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global FIC Single-target Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global FIC Single-target Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America FIC Single-target Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe FIC Single-target Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific FIC Single-target Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa FIC Single-target Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa FIC Single-target Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global FIC Single-target Drugs Revenue by Region
  1. 7.1 Global FIC Single-target Drugs Revenue by Region
  2. 7.1.1 Global FIC Single-target Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global FIC Single-target Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global FIC Single-target Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global FIC Single-target Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America FIC Single-target Drugs Revenue (2021-2032)
  8. 7.2.2 North America FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe FIC Single-target Drugs Revenue (2021-2032)
  11. 7.3.2 Europe FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific FIC Single-target Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa FIC Single-target Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa FIC Single-target Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi FIC Single-target Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson FIC Single-target Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis FIC Single-target Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck FIC Single-target Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche FIC Single-target Drugs Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly FIC Single-target Drugs Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer FIC Single-target Drugs Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Polarean lmaging
  44. 8.8.1 Polarean lmaging Company Information
  45. 8.8.2 Polarean lmaging Business Overview
  46. 8.8.3 Polarean lmaging FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Polarean lmaging FIC Single-target Drugs Product Portfolio
  48. 8.8.5 Polarean lmaging Recent Developments
  49. 8.9 Phathom
  50. 8.9.1 Phathom Company Information
  51. 8.9.2 Phathom Business Overview
  52. 8.9.3 Phathom FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Phathom FIC Single-target Drugs Product Portfolio
  54. 8.9.5 Phathom Recent Developments
  55. 8.10 Marinus
  56. 8.10.1 Marinus Company Information
  57. 8.10.2 Marinus Business Overview
  58. 8.10.3 Marinus FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Marinus FIC Single-target Drugs Product Portfolio
  60. 8.10.5 Marinus Recent Developments
  61. 8.11 Mallinckrodt
  62. 8.11.1 Mallinckrodt Company Information
  63. 8.11.2 Mallinckrodt Business Overview
  64. 8.11.3 Mallinckrodt FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mallinckrodt FIC Single-target Drugs Product Portfolio
  66. 8.11.5 Mallinckrodt Recent Developments
  67. 8.12 ImmunoGen
  68. 8.12.1 ImmunoGen Company Information
  69. 8.12.2 ImmunoGen Business Overview
  70. 8.12.3 ImmunoGen FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ImmunoGen FIC Single-target Drugs Product Portfolio
  72. 8.12.5 ImmunoGen Recent Developments
  73. 8.13 Immunocore
  74. 8.13.1 Immunocore Company Information
  75. 8.13.2 Immunocore Business Overview
  76. 8.13.3 Immunocore FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Immunocore FIC Single-target Drugs Product Portfolio
  78. 8.13.5 Immunocore Recent Developments
  79. 8.14 Gilead
  80. 8.14.1 Gilead Company Information
  81. 8.14.2 Gilead Business Overview
  82. 8.14.3 Gilead FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Gilead FIC Single-target Drugs Product Portfolio
  84. 8.14.5 Gilead Recent Developments
  85. 8.15 Genentech
  86. 8.15.1 Genentech Company Information
  87. 8.15.2 Genentech Business Overview
  88. 8.15.3 Genentech FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Genentech FIC Single-target Drugs Product Portfolio
  90. 8.15.5 Genentech Recent Developments
  91. 8.16 Dermavant Sciences
  92. 8.16.1 Dermavant Sciences Company Information
  93. 8.16.2 Dermavant Sciences Business Overview
  94. 8.16.3 Dermavant Sciences FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dermavant Sciences FIC Single-target Drugs Product Portfolio
  96. 8.16.5 Dermavant Sciences Recent Developments
  97. 8.17 Boehringer Ingelheim
  98. 8.17.1 Boehringer Ingelheim Company Information
  99. 8.17.2 Boehringer Ingelheim Business Overview
  100. 8.17.3 Boehringer Ingelheim FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Boehringer Ingelheim FIC Single-target Drugs Product Portfolio
  102. 8.17.5 Boehringer Ingelheim Recent Developments
  103. 8.18 BMS
  104. 8.18.1 BMS Company Information
  105. 8.18.2 BMS Business Overview
  106. 8.18.3 BMS FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BMS FIC Single-target Drugs Product Portfolio
  108. 8.18.5 BMS Recent Developments
  109. 8.19 Agios
  110. 8.19.1 Agios Company Information
  111. 8.19.2 Agios Business Overview
  112. 8.19.3 Agios FIC Single-target Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Agios FIC Single-target Drugs Product Portfolio
  114. 8.19.5 Agios Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 FIC Single-target Drugs Value Chain Analysis
  2. 9.1.1 FIC Single-target Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 FIC Single-target Drugs Production Mode & Process
  6. 9.2 FIC Single-target Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 FIC Single-target Drugs Distributors
  9. 9.2.3 FIC Single-target Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst